Red propolis hydroalcoholic extract inhibits the formation of
Journal
Journal of clinical and experimental dentistry
ISSN: 1989-5488
Titre abrégé: J Clin Exp Dent
Pays: Spain
ID NLM: 101603132
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
28
01
2020
accepted:
26
04
2020
entrez:
9
9
2020
pubmed:
10
9
2020
medline:
10
9
2020
Statut:
epublish
Résumé
To evaluate the antifungal activity of the red propolis hydroalcoholic extract (RPHE) against The minimum inhibitory and fungicidal concentrations (MIC and MFC) of the RPHE were determined by the microdilution technique. The MIC and MFC of RPHE were respectively 0.29 mg/mL (0.03%) and 1.17 mg/mL (0.12%). There was no difference in the microorganisms' viability (CFU/mL) among groups treated with RPHE (4.92×103), CHX (3.33×102) or NYS (6.8×104), being all of them different from NaCl (3.93×107) ( RPHE has antifungal activity against
Sections du résumé
BACKGROUND
BACKGROUND
To evaluate the antifungal activity of the red propolis hydroalcoholic extract (RPHE) against
MATERIAL AND METHODS
METHODS
The minimum inhibitory and fungicidal concentrations (MIC and MFC) of the RPHE were determined by the microdilution technique.
RESULTS
RESULTS
The MIC and MFC of RPHE were respectively 0.29 mg/mL (0.03%) and 1.17 mg/mL (0.12%). There was no difference in the microorganisms' viability (CFU/mL) among groups treated with RPHE (4.92×103), CHX (3.33×102) or NYS (6.8×104), being all of them different from NaCl (3.93×107) (
CONCLUSIONS
CONCLUSIONS
RPHE has antifungal activity against
Identifiants
pubmed: 32904863
doi: 10.4317/jced.56843
pii: 56843
pmc: PMC7462375
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e626-e631Informations de copyright
Copyright: © 2020 Medicina Oral S.L.
Déclaration de conflit d'intérêts
Conflicts of interest The authors declared that they have no conflicts of interest.
Références
J Pharm Bioallied Sci. 2017 Nov;9(Suppl 1):S241-S245
pubmed: 29284972
J Appl Microbiol. 2015 Apr;118(4):839-50
pubmed: 25565139
Methods. 2007 Aug;42(4):321-4
pubmed: 17560319
Evid Based Complement Alternat Med. 2014;2014:325670
pubmed: 25574178
BMC Oral Health. 2014 Jun 23;14:77
pubmed: 24957210
J Prosthet Dent. 2014 Oct;112(4):988-93
pubmed: 24726593
Adv Biochem Eng Biotechnol. 2015;147:59-110
pubmed: 25001990
Oral Dis. 2016 Apr;22(3):185-95
pubmed: 26456226
Bio Protoc. 2015 Aug 5;5(15):
pubmed: 27453914
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD007395
pubmed: 19821412
Planta Med. 2015 Aug;81(12-13):962-7
pubmed: 25922913
Int J Mol Sci. 2016 Oct 18;17(10):
pubmed: 27763544
Eur J Med Chem. 2016 Mar 3;110:267-79
pubmed: 26840367
Arch Oral Biol. 2018 May 23;93:56-65
pubmed: 29807235
BMC Complement Altern Med. 2018 Jul 18;18(1):219
pubmed: 30021632
J Oral Rehabil. 1999 Feb;26(2):97-102
pubmed: 10080305
Braz J Biol. 2019 Jul-Sep;79(3):452-459
pubmed: 30379200
J Am Geriatr Soc. 2016 Dec;64(12):2539-2545
pubmed: 27889906
Future Med Chem. 2015;7(4):493-512
pubmed: 25875875
Int J Prosthodont. 2012 Mar-Apr;25(2):113-9
pubmed: 22371829
Curr Med Chem. 2015;22(1):132-49
pubmed: 25245513
Nat Prod Res. 2014;28(16):1293-6
pubmed: 24666260
Ann N Y Acad Sci. 2015 Sep;1354:82-97
pubmed: 26509922
J Appl Microbiol. 2015 Sep;119(3):677-87
pubmed: 26086953
J Prosthet Dent. 2013 Nov;110(5):356-62
pubmed: 23998622
Evid Based Complement Alternat Med. 2015;2015:147804
pubmed: 25883668
Mem Inst Oswaldo Cruz. 2002 Oct;97(7):1027-31
pubmed: 12471432
Mycoses. 2010 Jan;53(1):12-5
pubmed: 19207850
Braz J Microbiol. 2016 Jan-Mar;47(1):159-66
pubmed: 26887239